You Are Here:
This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Farber Cancer Institute, Boston
Project Description: This project had three main goals:
Career Goals: Dr. Weingart is the Vice President for Patient Safety at the Dana-Farber Cancer Institute and Associate Professor of Medicine at the Harvard Medical School. He earned his Ph.D. in Public Policy from Harvard followed by his M.D. from the University of Rochester. He served his General Medicine residency at Beth Israel Deaconess Medical Center in Boston. The former grantee continues to conduct health services research in the field of patient safety.
Progress to Date: This grant has been completed. The implication of this series of studies was to demonstrate that hospitalized patients can provide information about adverse events and quality of care that is not captured through usual research methods (such as chart review) or administrative tools (such as hospital incident reports). In addition, the relationship between service quality and patient safety may offer a promising area of future investigation. If the safety climate in an organization supports effective communication and efficient care, this may manifest itself as favorable patient ratings of service quality as well as fewer medical errors and preventable adverse events. In addition, the lesions from inpatient care appear to hold in the ambulatory setting. Using E-mail prompts via a patient Internet portal, adult primary care patient can (and did) report medication-related symptoms including adverse drug events. Electronic medication safety reminders prompted a meaningful dialogue between patients and their clinicians, addressing a variety of issues and potential problems in medication safety.
Highlights and Specific Accomplishments:
K-Generated Publications (selected):
The information on this page is archived and provided for reference purposes only.